CN110353138A - 一种功能性饮品及其制备方法 - Google Patents
一种功能性饮品及其制备方法 Download PDFInfo
- Publication number
- CN110353138A CN110353138A CN201910737004.0A CN201910737004A CN110353138A CN 110353138 A CN110353138 A CN 110353138A CN 201910737004 A CN201910737004 A CN 201910737004A CN 110353138 A CN110353138 A CN 110353138A
- Authority
- CN
- China
- Prior art keywords
- parts
- flower
- functional beverage
- dandelion
- rose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 241000220317 Rosa Species 0.000 claims abstract description 15
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 15
- 241000026010 Dendrobium candidum Species 0.000 claims abstract description 14
- 239000009759 San-Chi Substances 0.000 claims abstract description 14
- 241000245665 Taraxacum Species 0.000 claims abstract description 14
- 241000208688 Eucommia Species 0.000 claims abstract description 13
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 12
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 12
- 241001145025 Saussurea involucrata Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 241000133134 Saussurea Species 0.000 claims abstract description 4
- 238000010790 dilution Methods 0.000 claims abstract description 4
- 239000012895 dilution Substances 0.000 claims abstract description 4
- 239000006166 lysate Substances 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 2
- 241000180649 Panax notoginseng Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 206010028980 Neoplasm Diseases 0.000 abstract description 10
- 201000011510 cancer Diseases 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- 230000001151 other effect Effects 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229930189092 Notoginsenoside Natural products 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002368 cardiac glycoside Substances 0.000 description 2
- 229940097217 cardiac glycoside Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229930002534 steroid glycoside Natural products 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- CCEAFOJVRQZWQC-UHFFFAOYSA-N Ddendroxine Natural products CC12C3CCC2CN2CCOC12C1C(C(C)C)C3C(=O)O1 CCEAFOJVRQZWQC-UHFFFAOYSA-N 0.000 description 1
- QSNCUGULHPBRGR-UHFFFAOYSA-N Dendramine Natural products CC12C3(O)CCC2CN(C)C1C1C(C(C)C)C3C(=O)O1 QSNCUGULHPBRGR-UHFFFAOYSA-N 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- CCEAFOJVRQZWQC-KFYGABLUSA-N Dendroxine Natural products O=C1O[C@@H]2[C@@H](C(C)C)[C@@H]1[C@H]1[C@]3(C)[C@@H](CN4[C@]23OCC4)CC1 CCEAFOJVRQZWQC-KFYGABLUSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- MAEQVSBPCIMMJF-UHFFFAOYSA-N Nobilonin Natural products CC(C)C1C2C(=O)C3(C)C(CN(C)C)CCC3C1C(=O)O2 MAEQVSBPCIMMJF-UHFFFAOYSA-N 0.000 description 1
- MAEQVSBPCIMMJF-MSZYXCAISA-N Nobilonine Natural products O=C1[C@@]2(C)[C@@H](CN(C)C)CC[C@H]2[C@H]2[C@H](C(C)C)[C@H]1OC2=O MAEQVSBPCIMMJF-MSZYXCAISA-N 0.000 description 1
- MYBAONSAUGZRAX-UBQYYSLZSA-N Notoginsenoside Fe Chemical class C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O MYBAONSAUGZRAX-UBQYYSLZSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- -1 Phenylpropanoid Glycosides Chemical class 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- ZOLPMMWNCLHKPX-UHFFFAOYSA-N ligustrin Natural products CC1=CCC2C1C3OC(=C)C(=O)C3C(O)CC2=C ZOLPMMWNCLHKPX-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种功能性饮品，包括以下重量份数的各原料：茶树花6‑26份，杜仲雄花5‑21份，铁皮石斛花4‑20份，蒲公英4‑20份，松花粉3‑19份，三七花3‑19份，玫瑰花5‑15份，代代花5‑15份，雪莲培养物1‑9份；一种功能性饮品的制备方法，包括以下步骤：步骤一、将茶树花、杜仲雄花、铁皮石斛花、蒲公英、松花粉、三七花、玫瑰花和代代花按照重量份数比例混合；步骤二、利用植物萃取技术，萃取步骤一中混合物的有效成分，然后加入指定重量份数的雪莲花培养物溶解液；步骤三、步骤二的混合液经微波灭菌、稀释后得到该功能性饮品；本发明经常饮用对人体有清热解毒，活血化瘀，增强免疫力，调理“三高”防癌抗癌等功效，功能多，使用效果好。
Description
技术领域
本发明涉及一种饮品，具体是一种功能性饮品及其制备方法。
背景技术
茶树花：茶树花中富含大量茶多酚和黄酮类物质，提高人体细胞活性；含微量元素硒和维生素E等天然抗癌成分，能预防细胞癌变也能抑制癌细胞的再生并有较强的解毒能力，有效把身体内的癌症病毒清理出体外；所含酚类物质能清理血液中的胆固醇软化血管，并有促进胰岛素分泌修复受损的胰岛细胞对治疗糖尿病维持血糖稳定有很大的效果。
杜仲雄花：该花含60多种天然活性成分，如木质素类，苯丙素类活性物质，黄酮、生物碱、氨基酸、多糖以及多种矿物质元素，能增强机体免疫功能，对于强肝，补肾，通便，降三高效果尤为显著。
铁皮石斛花：该花含有石斛碱，石斛胺，石斛次碱，石斛星碱以及多糖物质，能激活胰岛素，降低血糖，并含有酚类，菲类铜、脂类化合物，具有抗突变，抗肿瘤活性，杀灭肿瘤细胞，增强免疫功能，可用于恶性肿瘤辅助治疗作用，也能减轻化疗的副作用，提高患者的生存质量，延长生存时间。
蒲公英：其含有维生委A，维生素C及矿物质钾，钙、菊糖，蛋白质，碳水化合物以及微量元素，具有清热解毒，消炎健胃、利尿，增强免疫功能并有抗菌排毒，抗肿瘤等作用。
松花粉：其含有近百种酶类物质、30多种矿物质元素，14种维生素，长期食用可抗疲劳，保护心脑血管，提高免被力，保肝护肾，降脂降压，防癌抗癌，并能清除体内自油基，提高机体抗氧化酶类的活血，抑制脂质过氧化反应，延缓细胞衰老，保持机体组织活力并有调节功能紊乱等作用。
三七花：富含三七素，三七皂苷等独特的营养元素，并含有多种人参皂苷，三七多糖等成分，能提高免疫提经巨噬细胞的功能。三七总苷能提高血液中白细胞总数及淋巴细胞百分比，促进造血干细胞的增生，还能在一定程度上提高体液免疫抗体的生成；三七皂苷可通过直接杀灭肿瘤细胞，抑制肿瘤细胞的成长或转移，诱导肿瘤细胞凋亡或诱导肿瘤细胞分化使其逆转，增强和刺激机体免疫功能等多种方式起到抗肿瘤作用并有活血散瘀功效。
玫魂花：其中含有大量的维生素，氨基酸，可溶性糖，生物碱、蛋白质，脂肪，碳水化合物，钙，磷，钾，铁，镁等矿物质及多糖香酚，单宁酸等元素，能活血祛淤、降脂降压，并可帮助预防急慢性传染病、冠心病，肝病和阻止产生癌变物质。
代代花：此花含有多种黄酮类成分和强心甙，非强心甙，生物碱，辛弗林等多种成分，具有强心、利尿镇静及减慢心率的功能又有理气清血，促进血液循环，降脂健肾，顺气排毒，防癌抗癌等功效。
雪莲培养物：该物含有黄酮、多糖、绿原酸，紫丁香甙，蛋白质和氨基酸等有效成分，具有抑制非特异性免疫，细胞免疫以及增强体液免疫的功能，即具有免疫调节、人体酸碱度调节，从而增强人体免疫功能，也具有改善微循环抗辐射作用。秋水仙碱是细胞有丝分裂抑制癌细胞的增长，达到防癌抗癌的效果。
目前的功能性饮品作用较为单一，饮用效果差，不能满足人们多样化的需求。
发明内容
本发明的目的在于提供一种功能性饮品及其制备方法，以解决上述背景技术中提出的问题。
为实现上述目的，本发明提供如下技术方案：
一种功能性饮品，包括以下重量份数的各原料：茶树花6-26份，杜仲雄花5-21份，铁皮石斛花4-20份，蒲公英4-20份，松花粉3-19份，三七花3-19份，玫瑰花5-15份，代代花5-15份，雪莲培养物1-9份。
作为本发明进一步的方案：包括以下重量份数的各原料：茶树花11-21份，杜仲雄花10-16份，铁皮石斛花9-15份，蒲公英9-15份，松花粉8-14份，三七花8-14份，玫瑰花7-13份，代代花7-13份，雪莲培养物2-7份。
作为本发明进一步的方案：包括以下重量份数的各原料：茶树花16份，杜仲雄花13份，铁皮石斛花12份，蒲公英12份，松花粉11份，三七花11份，玫瑰花10份，代代花10份，雪莲培养物5份。
一种功能性饮品的制备方法，包括以下步骤：
步骤一、将茶树花、杜仲雄花、铁皮石斛花、蒲公英、松花粉、三七花、玫瑰花和代代花按照重量份数比例混合；
步骤二、利用植物萃取技术，萃取步骤一中混合物的有效成分，然后加入指定重量份数的雪莲花培养物溶解液；
步骤三、步骤二的混合液经微波灭菌、稀释后得到该功能性饮品。
与现有技术相比，本发明的有益效果是：
本发明采用上述的九种药食同源的植物按比例混合组成制备得到的饮品，所含成分和元素以及各种功效已得到广泛证实和认同，按比例配比，科学组合、含量互补、功效增强从而达到预防和调理高血脂，高血压，高血糖的作用；又能清热排毒，提高免疫能力；预防和对抗肿瘤的作用，从而增强人体素质，提升健康水平；经常饮用对人体有清热解毒，活血化瘀，增强免疫力，调理“三高”防癌抗癌等功效，功能多，使用效果好。
具体实施方式
下面结合具体实施方式对本专利的技术方案作进一步详细地说明。
实施例1
一种功能性饮品，包括以下重量份数的各原料：茶树花6-26份，杜仲雄花5-21份，铁皮石斛花4-20份，蒲公英4-20份，松花粉3-19份，三七花3-19份，玫瑰花5-15份，代代花5-15份，雪莲培养物1-9份。
实施例2
一种功能性饮品，包括以下重量份数的各原料：茶树花11-21份，杜仲雄花10-16份，铁皮石斛花9-15份，蒲公英9-15份，松花粉8-14份，三七花8-14份，玫瑰花7-13份，代代花7-13份，雪莲培养物2-7份。
实施例3
一种功能性饮品，包括以下重量份数的各原料：茶树花16份，杜仲雄花13份，铁皮石斛花12份，蒲公英12份，松花粉11份，三七花11份，玫瑰花10份，代代花10份，雪莲培养物5份。
上述实施例的制备方法，包括以下步骤：
步骤一、将茶树花、杜仲雄花、铁皮石斛花、蒲公英、松花粉、三七花、玫瑰花和代代花按照重量份数比例混合；
步骤二、利用植物萃取技术，萃取步骤一中混合物的有效成分，然后加入指定重量份数的雪莲花培养物溶解液；
步骤三、步骤二的混合液经微波灭菌、稀释后得到该功能性饮品。
上面对本专利的较佳实施方式作了详细说明，但是本专利并不限于上述实施方式，在本领域的普通技术人员所具备的知识范围内，还可以在不脱离本专利宗旨的前提下做出各种变化。
Claims (4)
1.一种功能性饮品，其特征在于，包括以下重量份数的各原料：茶树花6-26份，杜仲雄花5-21份，铁皮石斛花4-20份，蒲公英4-20份，松花粉3-19份，三七花3-19份，玫瑰花5-15份，代代花5-15份，雪莲培养物1-9份。
2.根据权利要求1所述的一种功能性饮品，其特征在于，包括以下重量份数的各原料：茶树花11-21份，杜仲雄花10-16份，铁皮石斛花9-15份，蒲公英9-15份，松花粉8-14份，三七花8-14份，玫瑰花7-13份，代代花7-13份，雪莲培养物2-7份。
3.根据权利要求2所述的一种功能性饮品，其特征在于，包括以下重量份数的各原料：茶树花16份，杜仲雄花13份，铁皮石斛花12份，蒲公英12份，松花粉11份，三七花11份，玫瑰花10份，代代花10份，雪莲培养物5份。
4.根据权利要求1-3任一权利要求所述的一种功能性饮品的制备方法，其特征在于，包括以下步骤：
步骤一、将茶树花、杜仲雄花、铁皮石斛花、蒲公英、松花粉、三七花、玫瑰花和代代花按照重量份数比例混合；
步骤二、利用植物萃取技术，萃取步骤一中混合物的有效成分，然后加入指定重量份数的雪莲花培养物溶解液；
步骤三、步骤二的混合液经微波灭菌、稀释后得到该功能性饮品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910737004.0A CN110353138A (zh) | 2019-08-10 | 2019-08-10 | 一种功能性饮品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910737004.0A CN110353138A (zh) | 2019-08-10 | 2019-08-10 | 一种功能性饮品及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110353138A true CN110353138A (zh) | 2019-10-22 |
Family
ID=68223674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910737004.0A Pending CN110353138A (zh) | 2019-08-10 | 2019-08-10 | 一种功能性饮品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110353138A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112189773A (zh) * | 2020-10-13 | 2021-01-08 | 江苏国仁堂健康科技有限公司 | 一种功能性饮品及其制备方法 |
| CN112717090A (zh) * | 2020-12-22 | 2021-04-30 | 梧州市华夏医药科技有限公司 | 一种杜仲雄花刺梨口服液及其应用 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104856009A (zh) * | 2015-04-23 | 2015-08-26 | 贵州广济堂药业有限公司 | 一种杜仲雄花保健品 |
| CN106031488A (zh) * | 2015-03-13 | 2016-10-19 | 哈尔滨浩拓生物科技开发有限公司 | 一种三七花清热生津汤料及其制备方法 |
| CN106720762A (zh) * | 2016-12-09 | 2017-05-31 | 张桂菊 | 一种花类凉茶 |
| CN106937718A (zh) * | 2017-02-21 | 2017-07-11 | 渭南敬贤堂科技有限责任公司 | 一种双海藻花粉植物复合饮料及其制备方法 |
| CN107788316A (zh) * | 2017-12-08 | 2018-03-13 | 毛义良 | 一种保健饮料 |
| CN108671002A (zh) * | 2018-05-31 | 2018-10-19 | 南京中生生物科技有限公司 | 一种含雪莲培养物提取物的组合物及其应用 |
| CN108967785A (zh) * | 2018-07-20 | 2018-12-11 | 程国青 | 一种蒲公英饮料的配方及制备工艺 |
-
2019
- 2019-08-10 CN CN201910737004.0A patent/CN110353138A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106031488A (zh) * | 2015-03-13 | 2016-10-19 | 哈尔滨浩拓生物科技开发有限公司 | 一种三七花清热生津汤料及其制备方法 |
| CN104856009A (zh) * | 2015-04-23 | 2015-08-26 | 贵州广济堂药业有限公司 | 一种杜仲雄花保健品 |
| CN106720762A (zh) * | 2016-12-09 | 2017-05-31 | 张桂菊 | 一种花类凉茶 |
| CN106937718A (zh) * | 2017-02-21 | 2017-07-11 | 渭南敬贤堂科技有限责任公司 | 一种双海藻花粉植物复合饮料及其制备方法 |
| CN107788316A (zh) * | 2017-12-08 | 2018-03-13 | 毛义良 | 一种保健饮料 |
| CN108671002A (zh) * | 2018-05-31 | 2018-10-19 | 南京中生生物科技有限公司 | 一种含雪莲培养物提取物的组合物及其应用 |
| CN108967785A (zh) * | 2018-07-20 | 2018-12-11 | 程国青 | 一种蒲公英饮料的配方及制备工艺 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112189773A (zh) * | 2020-10-13 | 2021-01-08 | 江苏国仁堂健康科技有限公司 | 一种功能性饮品及其制备方法 |
| CN112717090A (zh) * | 2020-12-22 | 2021-04-30 | 梧州市华夏医药科技有限公司 | 一种杜仲雄花刺梨口服液及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101501326B1 (ko) | 함초, 민들레, 생강나무 등 125가지의 원재료를 생물의 물성에 따라 CO2(또는 N2) Carrier Gas를 이용하여 추출농축, 설탕 절임 후 추출 및 Microwave와 Filter를 이용하여 추출한 추출물들을 혼합숙성하여 제조한 조성물과 그 제조방법 | |
| KR20130029098A (ko) | 누에와 뽕나무잎과 상지(桑枝)를 이용한 이온미네랄 제조방법 및 이에 의해 제조 된 건강음료 | |
| CN101612315A (zh) | 一种用于调整人体机能的中药复方制剂 | |
| CN103156017A (zh) | 一种减肥降脂的黑茶饮料及其制备方法 | |
| CN110353138A (zh) | 一种功能性饮品及其制备方法 | |
| CN103653144A (zh) | 提高免疫力的保健饮料其制备方法 | |
| CN101411488A (zh) | 人参果茶 | |
| CN105770420A (zh) | 一种具有抗癌作用的中草药剂及其制备方法 | |
| CN108175785A (zh) | 金花葵复合保健饮品及其制备方法 | |
| CN105285649A (zh) | 一种养颜蜂蜜固体饮料及其制备方法 | |
| KR20100112215A (ko) | 주성분으로 해양심층수, 홍삼 추출물, 대추 엑기스, 천궁 엑기스, 감초엑기스 및 구기자 엑기스를 주성분으로 함유하는 기능성 음료조성물 | |
| CN103653104B (zh) | 具有消脂及保护心血管作用的石榴复合饮料及其制备方法和应用 | |
| CN103695274B (zh) | 一种高丽参酒的制备方法 | |
| CN111387345A (zh) | 一种复合多糖组合物及其制备方法 | |
| CN109730222A (zh) | 酵素复合液及其保健饮料 | |
| CN108771236A (zh) | 一种养生梨膏及其制作方法 | |
| KR102436045B1 (ko) | 생약재 미네랄 효모 발효액을 이용하여 제조되는 발효 흑삼 조성물 및 그 제조방법 | |
| CN101642256B (zh) | 一种去痘美容牛奶的制作方法 | |
| RU2743292C1 (ru) | Средство для лечения желчекаменной и мочекаменной болезней | |
| KR101606913B1 (ko) | 강황을 이용한 건강음료 제조방법 | |
| CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 | |
| KR102592954B1 (ko) | 골밀도 증진을 촉진하는 조성물 제조방법 | |
| CN109730174A (zh) | 一种降压降脂茶 | |
| KR102616632B1 (ko) | 다슬기를 주원료로 하는 건강보조식품 및 이의 제조방법 | |
| CN102823405B (zh) | 一种治疗高血压人参的培育方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191022 |
|
| RJ01 | Rejection of invention patent application after publication |